Veradermics MANE
NYSE MANE
$121.37 +3.56 (+3.02%)
At close: Sep 30, 2026 · 4:00 PM EDT

Veradermics (MANE) Non Operating Income (2025 - 2026)

Updated

Veradermics (MANE) recorded Non Operating Income of $6.05 million in Q2 2026, compared with $428,000 a year earlier and up 130.1% from the prior quarter.

Analysis

Veradermics (MANE) Non Operating Income (2025 - 2026) Analysis & Trends

On a TTM basis, Veradermics' Non Operating Income came in at $9.62 million as of Jun 30, 2026; for FY2025, it came in at $2.35 million, up 711.0% from FY2024.

  • Across earlier years, Non Operating Income came in at $290,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Veradermics 5.07 Bn 5.07 Bn - 6.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.05 Mn
Mar 31, 2026 2.63 Mn
Jun 30, 2025 428,000.00
Mar 31, 2025 515,000.00
API Access

Veradermics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=MANE&period=max&api_key=YOUR_API_KEY